97056 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS
#302IL-1 RECEPTOR ANTAGONIST (IL-1 RA) FUSION PROTEINS BINDING TO THE EXTRACELLULAR MATRIX
#303Anti-VEGF protein compositions and methods for producing the same
#304MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
#305COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLAMMATION
#306Nucleic acids encoding switch receptors using IL-9 receptor signaling domains
#307METHODS OF USING ACTIVIN RECEPTOR TYPE IIA VARIANTS
#308TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF
#309COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION
#310TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE, FUSION PROTEIN OF TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE AND ANTI-EGFR ANTIBODY, AND ANTI-TUMOR USE OF FUSION PROTEIN
#311COMPOSITION FOR OVERCOMING RESISTANCE TO EGFR-TARGETING AGENT
#312Liquid Formulation of a VEGF Antagonist
#313SLAMF7 CARS
#314MUTATION COMPLEX INCLUDING GAIN-OF-FUNCTION MUTANT OF BMPR2 GENE, INDUCED PLURIPOTENT STEM CELLS AND MESENCHYMAL STEM CELLS DERIVED FROM MUTANT, AND USE THEREOF
#315BIFUNCTIONAL PROTEIN AGAINST PD-1 AND TGF-BETA
#316Anti-VEGF protein compositions and methods for producing the same
#317COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#318Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to treat cancer
#319Fusion proteins comprising an engineered knottin peptide and uses thereof
#320SOMATOSTATIN RECEPTOR-BASED CANCER THERAPY
#321Cells expressing recombinant growth factor receptors
#322NUCLEIC ACID ENCODING AN ANTI-VEGF ENTITY AND A NEGATIVE COMPLEMENT REGULATOR AND USES THEREOF FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#323MODIFIED NATURAL KILLER CELLS AND METHODS OF USING THE SAME
#324A PEPTIDE COCKTAIL
#325ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
#326Screening method for effective target - E3 ligase combinations
#327VARIANT ACTRIIB PROTEINS AND USES THEREOF
#328METHODS OF TREATING CANCER USING A COMBINATION OF TUMOR MEMBRANE VESICLES AND METFORMIN
#329METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#330EPIDERMAL GROWTH FACTOR RECEPTOR
#331MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY-MODIFIED CELLS
#332ACTRII PROTEINS AND USE IN TREATING POST-CAPILLARY PULMONARY HYPERTENSION
#333TAGGED GENE EDITING TECHNOLOGY FOR CLINICAL CELL SORTING AND ENRICHMENT
#334METHOD FOR CULTURING CELL POPULATION CONTAINING CARTILAGE-DERIVED Tie2-POSITIVE CELLS AND USE OF SAID METHOD
#335ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF
#336ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING ANEMIA
#337LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION
#338SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING RENAL DISEASES OR CONDITIONS
#339COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#340MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
#341COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE
#342Anti-VEGF protein compositions and methods for producing the same
#343DETECTION OF NOVEL DEGRADATION-RELATED INTERACTIONS
#344SYSTEM FOR COVALENTLY LINKING PROTEINS
#345OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM
#346FUSION PROTEINS AND USES THEREOF
#347FUSION PROTEINS FOR SELECTIVELY DEPLETING ANTIGEN-SPECIFIC ANTIBODIES
#348POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF
#349ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF
#350A BIFUNCTIONAL FUSION PROTEIN AND USES THEREOF
#351Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#352Anti-VEGF protein compositions and methods for producing the same
#353VEGF MINI-TRAPS AND METHOD OF USE THEREOF
#354TGFBR2-BASED CHIMERIC PROTEINS
#355ENGINEERED T CELLS
#356Anti-VEGF protein compositions and methods for producing the same
#357LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION
#358REGULATABLE CHIMERIC ANTIGEN RECEPTOR
#359VEGFR-FC FUSION PROTEIN FORMULATIONS
#360Multi-functional and multi-valent interleukin-TGF-beta receptor fusion polypeptides
#361ROR1 targeting chimeric antigen receptor
#362ANTI-PD-L1 ANTIGEN BINDING PROTEIN AND APPLICATION THEREOF
#363CHIMERIC RECEPTOR PROTEINS AND USES THEREOF
#364CHIMERIC RECEPTOR SENSORS
#365Anti-VEGF protein compositions and methods for producing the same
#366TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF
#367MULTISPECIFIC ANTAGONISTS
#368Anti-VEGF protein compositions and methods for producing the same
#369TRANSGENE GENETIC TAGS AND METHODS OF USE
#370ENGINEERED RECEPTORS FOR HUMAN CYTOMEGALOVIRUS AND USES THEREOF
#371CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE
#372DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS
#373Multispecific binders of TGFBeta-superfamily ligands and uses thereof
#374Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#375Methods and compositions for reducing the immunogenicity of chimeric notch receptors
#376Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#377Compositions and methods comprising engineered chimeric antigen receptor and modulator of CAR
#378METHODS AND COMPOSITIONS FOR REDUCING THE IMMUNOGENICITY OF CHIMERIC NOTCH RECEPTORS
#379NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#380METHOD FOR PRODUCING FUSION PROTEIN HAVING IGG FC DOMAIN
#381VACCINE FOR THE PREVENTION OF BREAST CANCER RELAPSE
#382RECOMBINANT PROTEIN TARGETING PD-L1 AND VEGF
#383PEPTIDE MIMETICS OF DKK3b AND METHODS OF USE
#384ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF
#385Methods for treating muscle wasting and bone disease using novel hybrid ActRIIB ligand trap proteins
#386METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS
#387METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS BY REPROGRAMMING SOMATIC CELLS
#388MULTIMERIC PROTEIN DOMAINS FOR MULTIFUNCTIONALITY AND ENHANCED SECRETION OF THERAPEUTIC PROTEINS
#389NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#390ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF
#391SINGLE-ARM TYPE I AND TYPE II RECEPTOR FUSION PROTEINS AND USES THEREOF
#392GENE FRAGMENT OVEREXPRESSION SCREENING METHODOLOGIES, AND USES THEREOF
#393Variant ActRIIB proteins and uses thereof
#394CHIMERIC PROTEINS IN AUTOIMMUNITY
#395ALK1 receptor and ligand antagonists and uses thereof
#396ALK7 antagonists and uses thereof
#397FUSION PROTEIN TARGETING PD-L1 AND TGF-ß AND USE THEREOF
#398TGF-beta TRAP
#399Netrin G1 And Netrin G1 Ligand Peptides And Antibodies And Uses Thereof
#400COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MACULAR DEGENERATION
#401MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF
#402NOVEL COMPOSITION COMPRISING ANTIBODIES
#403VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR
#404METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY
#405Peptides and combination of peptides for use in immunotherapy against various cancers
#406Peptides and combination of peptides for use in immunotherapy against various cancers
#407DRUG TARGET OF IDIOPATHIC PULMONARY FIBROSIS
#408Anti-VEGF protein compositions and methods for producing the same
#409NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#410Use of a VEGF antagonist to treat angiogenic eye disorders
#411EGFR AND ROS1 KINASE IN CANCER
#412METHODS AND COMPOSITIONS FOR TARGETING TGF-ß SIGNALING IN CD4+ HELPER T CELLS FOR CANCER IMMUNOTHERAPY
#413REFINING METHOD OF OPHTHALMIC PROTEIN PHARMACEUTICAL
#414COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF
#415Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#416CHIMERIC ANTIGEN RECEPTORS TARGETING HER2
#417Peptides and combination of peptides for use in immunotherapy against various cancers
#418Peptides and combination of peptides for use in immunotherapy against various cancers
#419Peptides and combination of peptides for use in immunotherapy against various cancers
#420FUSION PROTEIN OF ETA ANTIBODY AND TGF-BETA TRAP AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#421ActRIIa and ALK4 polypeptides for treating kidney fibrosis, inflammation and injury
#422Peptides and combination of peptides for use in immunotherapy against various cancers
#423Peptides and combination of peptides for use in immunotherapy against various cancers
#424Method of treating or ameliorating a pathogenic infection by administering an interleukin-2/TGF-β receptor fusion polypeptide
#425SYSTEMS AND METHODS FOR GENE THERAPY VIA ADMINISTRATION OF GENETICALLY MODIFIED VIRAL VECTORS
#426Exosome-based anticancer agent
#427Peptides and combination of peptides for use in immunotherapy against various cancers
#428ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#429ALK4:actriib heteromultimers and uses thereof
#430VACCINE FOR THE PREVENTION OF BREAST CANCER RELAPSE
#431ANTI-NOTCH3 ANTIBODY
#432Anti-VEGF protein compositions and methods for producing the same
#433METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS
#434Anti-VEGF protein compositions and methods for producing the same
#435Anti-VEGF protein compositions and methods for producing the same
#436METHODS AND COMPOSITIONS COMPRISING ENHANCED TARGETED IMMUNE GENE THERAPY FOR THE TREATMENT OF CANCER
#437FULLY HUMAN ANTIBODY TARGETING CD19 AND APPLICATION THEREOF
#438BIFUNCTIONAL FUSION PROTEIN AGAINST PDL1 AND TGFß AND USE THEREOF
#439PEPTIDES
#440METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS
#441METHODS FOR TREATING HETEROTOPIC OSSIFICATION
#442COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS
#443ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS
#444TGF-β-receptor ectodomain fusion molecules and uses thereof
#445ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS
#446COMBINATORIAL CAR T CELL AND HEMATOPOEITIC STEM CELL GENETIC ENGINEERING FOR SPECIFIC IMMUNOTHERAPY OF MYELOID LEUKEMIAS
#447Neoantigen peptide mimics
#448CELLS EXPRESSING A RECOMBINANT RECEPTOR FROM A MODIFIED TGFBR2 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS
#449Genetically Engineered Cells and Uses Thereof
#450COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING HER2 EXON 21 INSERTIONS
#451TRUNCATED ACTRIIB-FC FUSION PROTEINS
#452Anti-angiogenesis fusion protein and uses thereof
#453NOVEL FUSION MOLECULES AND USES THEREOF
#454TGF-B-RECEPTOR ECTODOMAIN FUSION MOLECULES AND USES THEREOF
#455Anti-VEGF protein compositions and methods for producing the same
#456CELLULAR THERAPEUTICS ENGINEERED WITH SIGNAL MODULATORS AND METHODS OF USE THEREOF
#457MUC16 specific chimeric antigen receptors and uses thereof
#458MUC16 specific chimeric antigen receptors and uses thereof
#459Advanced avatar dendritic cells
#460Recombinant proteins and their therapeutic uses
#461T CELL RECEPTORS AND METHODS OF USE THEREOF
#462COMPOSITIONS AND METHODS COMPRISING ENGINEERED CHIMERIC ANTIGEN RECEPTOR AND MODULATOR OF CAR
#463Long-acting VEGF inhibitors for intraocular neovascularization
#464A MEMBRANE-BOUND FIT-1 DECOY AND USES THEREOF
#465Smart single-domain intrabodies with precision switches for biomedical applications
#466Multi-functional and multi-valent interleukin-TGF-beta receptor fusion polypeptides
#467Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
#468BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH
#469FIBRONECTIN BASED SCAFFOLD PROTEINS HAVING IMPROVED STABILITY
#470ALK7:ActRIIB heteromultimers and uses thereof
#471MODIFIED IL-12 T CELL THERAPY FOR THE TREATMENT OF CANCER
#472Glyco-engineered immunization antigens
#473TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#474METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS
#475MULTI-TARGETING FUSION PROTEIN FOR BLOCKING THE GROWTH OF VASCULAR ENDOTHELIAL CELLS AND ACTIVATING T CELLS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#476Anti-VEGF protein compositions and methods for producing the same
#477AFLIBERCEPT ATTRIBUTES AND METHODS OF CHARACTERIZING AND MODIFYING THEREOF
#478USE OF ONCOLYTIC VIRUSES FOR THE TREATMENT OF CANCER
#479KLOTHO BETA
#480PDGF RECEPTOR BETA BINDING POLYPEPTIDES
#481BI-AND TRI-FUNCTIONAL FUSION PROTEINS AND USES THEREOF
#482Protein M fusion proteins and uses
#483Compositions and methods for treating spinal muscular atrophy
#484METHOD FOR DETECTING HOST CELL PROTEINS IN THERAPEUTIC ANTIBODIES BY COMBINING TRYPSIN DIGESTION, CHROMATOGRAPHY GRADIENTS, AND BOXCAR MASS SPECTROMETRY
#485COMBINATION THERAPY COMPRISING CANCER-TARGETED CAR-T CELLS AND A METHOD OF USING SAME FOR A TREATMENT FOR CANCER
#486Expression of novel cell tags
#487ANTIBODIES AND METHODS OF USE
#488Cross species single domain antibodies targeting mesothelin for treating solid tumors
#489Drug regulated transgene expression
#490FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF
#491CD22-SPECIFIC T CELL RECEPTORS AND ADOPTIVE T CELL THERAPY FOR TREATMENT OF B CELL MALIGNANCIES
#492Recombinant poxviruses for cancer immunotherapy
#493Engineered immune cells targeting BCMA and their uses thereof
#494Anti-VEGF protein compositions and methods for producing the same
#495IGFR-like 2 receptor and uses thereof
#496Truncated Epiderimal Growth Factor Receptor (EGFRt) for Transduced T Cell Selection
#497PLASMID CONSTRUCTS FOR TREATING CANCER AND METHODS OF USE
#498A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS)
#499Breast and ovarian cancer vaccines
#500Anti-VEGF protein compositions and methods for producing the same
#501Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
#502CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER-FAMILY RECEPTORS
#503BTLA fusion protein agonists and uses thereof
#504Erythropoietin Analogs For Veterinary Use
#505Fusion constructs and methods of using thereof
#506Pharmaceutical compositions and methods targeting Wnt pathway proteins
#507METHODS FOR INCREASING THERMOGENIC ADIPOCYTES
#508Combination Therapy for Cancer
#509TGF-beta RECEPTOR FUSION PROTEIN PHARMACEUTICAL COMPOSITION AND USE THEREOF
#510METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION
#511Anti-VEGF protein compositions and methods for producing the same
#512Anti-VEGF protein compositions and methods for producing the same
#513Anti-VEGF protein compositions and methods for producing the same
#514BI-FUNCTIONAL ARGININE-GLYCINE-ASPARTIC ACID (RGD) PEPTIDES AND METHODS TO PROMOTE ANGIOGENESIS
#515Gene mutations and copy number alterations of EGFR, KRAS and MET
#516GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS
#517VEGF Antagonist Formulations
#518CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN
#519CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN
#520PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF
#521METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION
#522BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS
#523ACVR2A-SPECIFIC ANTIBODY AND METHOD OF USE THEREOF
#524HCMV ENTRY INHIBITORS
#525Binders of TGFβ-superfamily ligands and uses thereof
#526WNT/SFRP COMPLEXES, WNT-CONTAINING COMPOSITIONS, WNT-EXPRESSING CELLS, AND METHODS OF MAKING, PURIFYING, AND USING SAME
#527Chimeric antigen receptors targeting glypican-3 or mesothelin
#528METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
#529TGF- RECEPTOR II ISOFORM, FUSION PEPTIDE, METHODS OF TREATMENT AND METHODS IN VITRO
#530Anti-VEGF protein compositions and methods for producing the same
#531SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES THEREOF
#532COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING HER2 EXON 19 MUTATIONS
#533ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS
#534ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS
#535Peptides and combination of peptides for use in immunotherapy against various cancers
#536Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of use
#537VEGF traps and mini-traps and methods for treating ocular disorders and cancer
#538Peptides and combination of peptides for use in immunotherapy against various cancers
#539Breast and ovarian cancer vaccines
#540VEGF antagonist formulations suitable for intravitreal administration
#541CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS METABOLISM MOLECULES MODULATING INTRACELLULAR LACTATE CONCENTRATIONS AND THERAPEUTIC USES THEREOF
#542GFRAL EXTRACELLULAR DOMAINS AND METHODS OF USE
#543Compositions and methods of treating cancer with chimeric antigen receptors
#544Expression of novel cell tags
#545CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#546Methods and compositions comprising B7H3 chimeric antigen receptors
#547Transforming growth factor-beta (TGF-beta) receptor type II fusion polypeptides
#548Bifunctional angiogenesis inhibitor and use thereof
#549PEPTIDES FROM NPSR1
#550Methods and compositions for treating myelofibrosis
#551COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH RTK MUTANT CELLS
#552SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#553Bacteriophage-Based Antibodies and Binders
#554Bispecific chimeric antigen receptors, encoding polynucleotides thereof and methods of use thereof to treat disease
#555Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
#556Recombinant cell surface markers
#557Use of a VEGF antagonist to treat angiogenic eye disorders
#558Use of a VEGF antagonist to treat angiogenic eye disorders
#559Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein
#560Compositions and methods for treating pulmonary hypertension
#561Compositions and methods for treating pulmonary hypertension
#562Systems, methods, and kits for diagnostics and treatment of viral respiratory infection
#563METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER
#564Peptides and combination of peptides for use in immunotherapy against various cancers
#565Peptides and combination of peptides for use in immunotherapy against various cancers
#566KLOTHO BETA
#567Anti-VEGF protein compositions and methods for producing the same
#568Peptides and combination of peptides for use in immunotherapy against various cancers
#569Methods of treating cholangiocarcinoma
#570Anti-HER3 humanized monoclonal antibody
#571NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#572Nucleic acid molecules encoding activin receptor type IIA variants
#573Materials and methods for treatment with oncolytic viruses and modified CAR T cells
#574Immune cell compositions and methods of use for treating viral and other infections
#575Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof
#576METHODS FOR TREATING FATTY LIVER DISEASE
#577METHODS OF TREATING CANCER BASED ON IDENTIFYING MUTATIONS IN THE EXTRACELLULAR DOMAIN III OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE
#578ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING MULTIPLE MYELOMA
#579ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF
#580COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS
#581Muscle performance improvement compounds comprising C-terminus agrin fragment and an ACTR2B inhibitor
#582VEGF Antagonist Formulations
#583Antitumor antagonists
#584COMBINED INHIBITION OF PD-1/PD-L1, TGFB AND DNA-PK FOR THE TREATMENT OF CANCER
#585Antibodies and chimeric antigen receptors specific for ROR1
#586De Novo Formation of the Biliary System by Hepatocyte Transdifferentiation
#587Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors
#588TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF
#589METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS
#590BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
#591OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM
#592Anti-VEGF protein compositions and methods for producing the same
#593Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
#594EGFR and C-met fibronectin type III domain binding molecules
#595Fusion proteins comprising an engineered knottin peptide and uses thereof
#596Chimeric Growth Factor Receptors
#597Peptidic TGF-beta antagonists
#598Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor
#599Anti-CD19 CAR-T cell
#600AAV vectors for retinal and CNS gene therapy